Physician profile
Emily E Hunt
NPI 1619333242
$7,158.94
in general payments reported to CMS, 2019-2025
32 companies · $3,455 in 2025
The $3,455 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $100 · 2022: $308 · 2023: $1,185 · 2024: $2,111 · 2025: $3,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,631 · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,631.08 |
| Education | $119.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $900.46 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $813.81 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Cequr Corporation | $809.11 | 2024-2025 | Cequr Simplicity |
| Dexcom, INC. | $730.30 | 2022-2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $602.56 | 2023-2025 | Korlym |
| Amgen INC. | $418.98 | 2023-2025 | Repatha, Repatha, Evenity |
| Radius Health, INC. | $359.00 | 2023-2025 | Tymlos |
| Beta Bionics, INC. | $347.96 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Sequel Med Tech, LLC | $280.32 | 2025 | Twiist |
| Sanofi-Aventis U.S. LLC | $216.69 | 2023-2025 | |
| Insulet Corporation | $211.01 | 2023-2025 | Omnipod |
| Xeris Pharmaceuticals, INC. | $189.78 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Novartis Pharmaceuticals Corporation | $152.66 | 2022-2025 | |
| Medtronic, INC. | $145.37 | 2023-2025 | Minimed 780g |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.01 | 2023-2025 | Jardiance |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $100.27 | 2021 | |
| Amneal Pharmaceuticals LLC | $89.98 | 2023-2025 | Unithroid |
| Mannkind Corporation | $75.26 | 2025 | |
| Tandem Diabetes Care, INC. | $71.93 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amphastar Pharmaceuticals, INC. | $70.82 | 2025 | |
| Esperion Therapeutics, INC. | $63.30 | 2024-2025 | Nexletol |
| Abbott Laboratories | $61.95 | 2023-2024 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $52.35 | 2022-2023 | Lokelma |
| Ascensia Diabetes Care US INC. | $48.38 | 2023 | |
| Horizon Therapeutics Plc | $33.24 | 2023 | Tepezza |
| Kyowa Kirin, INC. | $33.09 | 2023 | Crysvita |
| Tolmar, INC. | $31.98 | 2024 | |
| Sanofi US Services INC. | $24.74 | 2024 | |
| Abbvie INC. | $22.81 | 2024 | |
| Antares Pharma, INC. | $19.84 | 2024 | Xyosted |
| Kowa Pharmaceuticals America, INC. | $18.69 | 2023 | Livalo |
| Pfizer INC. | $17.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.